In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Buy rating on Novo Nordisk (0QIU – Research Report), with a ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Yields on European government bonds remained elevated, with the German 10-year bund yield hitting its highest level in six ...

The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...

Deutsche Bank analyst Emmanuel Papadakis lowered the firm’s price target on Novo Nordisk (NVO) to DKK 900 from DKK 1,000 and keeps a Buy rating ...

Investing.com – Denmark stocks were higher after the close on Wednesday, as gains in the Personal & Household Goods, Industrials and Chemicals sectors led shares higher. At the... Investing.com ...

Hotter-than-expected jobs data and bond yields pressured stocks, resulting in weekly losses for all three indexes ...

U.S. President-elect Donald Trump will not go to jail or face any other punishment for his criminal conviction stemming from hush money paid to a porn star, a judge ruled on Friday but said Trump ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

The semiconductor maker has underperformed peers amid a contrast between the haves and the have-nots in the chip sector, the bank says.